RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells

Jun Dong Wei; Jae Hyun Jang; Jae Hong Kim

doi:10.1016/j.bbrc.2016.12.147

RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells

Jun Dong Wei, Jae Hyun Jang, Jae Hong Kim

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B₄ receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.

Original language	English
Pages (from-to)	305-311
Number of pages	7
Journal	Biochemical and biophysical research communications
Volume	483
Issue number	1
DOIs	https://doi.org/10.1016/j.bbrc.2016.12.147
Publication status	Published - 2017 Jan 29

Bibliographical note

Funding Information:
This work was supported by Bio & Medical Technology Development Program grants (2012M3A9C5048709 and 2012M3A9C1053532) and a Mid-Career Researcher Program grant (2015R1A2A1A15053311) through the National Research Foundation (NRF) funded by the Ministry of Science, Information and Communication Technologies (ICT) and Future Planning of the Republic of Korea. This work was also supported by Basic Science Research (2015R1D1A1A01057757) through the NRF funded by the Ministry of Education and by the BK21 Plus Program (College of Life Sciences and Biotechnology, Korea University), as well as a Korea University Grant.

Publisher Copyright:
© 2016 Elsevier Inc.

Keywords

BLT2
Breast cancer
IL-8
Invasiveness
RanBPM

ASJC Scopus subject areas

Biophysics
Biochemistry
Molecular Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bbrc.2016.12.147

Cite this

@article{0aea8a8418544295a061b0003cd69e40,

title = "RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells",

abstract = "RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.",

keywords = "BLT2, Breast cancer, IL-8, Invasiveness, RanBPM",

author = "Wei, {Jun Dong} and Jang, {Jae Hyun} and Kim, {Jae Hong}",

note = "Funding Information: This work was supported by Bio & Medical Technology Development Program grants (2012M3A9C5048709 and 2012M3A9C1053532) and a Mid-Career Researcher Program grant (2015R1A2A1A15053311) through the National Research Foundation (NRF) funded by the Ministry of Science, Information and Communication Technologies (ICT) and Future Planning of the Republic of Korea. This work was also supported by Basic Science Research (2015R1D1A1A01057757) through the NRF funded by the Ministry of Education and by the BK21 Plus Program (College of Life Sciences and Biotechnology, Korea University), as well as a Korea University Grant. Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2017",

month = jan,

day = "29",

doi = "10.1016/j.bbrc.2016.12.147",

language = "English",

volume = "483",

pages = "305--311",

journal = "Biochemical and biophysical research communications",

issn = "0006-291X",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells

AU - Wei, Jun Dong

AU - Jang, Jae Hyun

AU - Kim, Jae Hong

N1 - Funding Information: This work was supported by Bio & Medical Technology Development Program grants (2012M3A9C5048709 and 2012M3A9C1053532) and a Mid-Career Researcher Program grant (2015R1A2A1A15053311) through the National Research Foundation (NRF) funded by the Ministry of Science, Information and Communication Technologies (ICT) and Future Planning of the Republic of Korea. This work was also supported by Basic Science Research (2015R1D1A1A01057757) through the NRF funded by the Ministry of Education and by the BK21 Plus Program (College of Life Sciences and Biotechnology, Korea University), as well as a Korea University Grant. Publisher Copyright: © 2016 Elsevier Inc.

PY - 2017/1/29

Y1 - 2017/1/29

N2 - RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.

AB - RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.

KW - BLT2

KW - Breast cancer

KW - IL-8

KW - Invasiveness

KW - RanBPM

UR - http://www.scopus.com/inward/record.url?scp=85009259968&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2016.12.147

DO - 10.1016/j.bbrc.2016.12.147

M3 - Article

C2 - 28027932

AN - SCOPUS:85009259968

SN - 0006-291X

VL - 483

SP - 305

EP - 311

JO - Biochemical and biophysical research communications

JF - Biochemical and biophysical research communications

IS - 1

ER -

RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this